Mounjaro®
Starting from £179.99/mo
Start journey Learn moreGiving yourself a Mounjaro injection for the first time can feel daunting, but the KwikPen is designed to make administration straightforward. You inject tirzepatide once a week, subcutaneously, into the abdomen, thigh, or upper arm, rotating sites each time. Mounjaro is a prescription-only medicine; a GPhC-registered prescriber assesses your suitability before any treatment begins. This guide covers the practical steps accurately, using the published Mounjaro Summary of Product Characteristics — but always read the Patient Information Leaflet supplied in your pack, as it is the authoritative instruction for your specific dose. If you have any concerns about your technique, our clinical team is available seven days a week.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Most people approach their first Mounjaro injection expecting something clinical and fiddly. The reality is almost the opposite. The KwikPen requires no mixing, no dose-setting dial, and no visible needle, the needle is fully enclosed until the moment of injection and retracts automatically afterwards. A first-timer who has read the leaflet carefully can usually complete the process in under a minute.
The misconception worth correcting first is that subcutaneous injection is the same as intramuscular injection. It is not. You are depositing tirzepatide into the layer of fatty tissue just beneath the skin, not into muscle. That means a shorter needle, a shallower angle (the pen handles this), and far less discomfort than most people anticipate. A question our prescribers hear most weeks is whether it is supposed to hurt; for the majority of patients the sensation is a brief pinch, not pain.
Understanding this before you begin matters because anxiety about injection technique is one of the most common reasons people delay starting treatment or, worse, use a rushed technique that delivers the medicine less reliably. The full Mounjaro injection instructions on this site walk through each step in detail, but the outline is straightforward.
Before you begin, wash your hands thoroughly. Remove the pen from the fridge and allow it to reach room temperature for a few minutes, this is not a clinical requirement but many people find a cold pen more uncomfortable. Check the expiry date and the medicine window; the liquid should be clear and colourless. Do not use a pen that looks cloudy or contains particles. Attach a new needle, following the instructions in the leaflet. A pack of compatible replacement needles is worth keeping alongside your pens so you never find yourself short.
Choose your injection site. The abdomen, outer thigh, and outer upper arm are all licensed for tirzepatide. Avoid broken, bruised, or irritated skin. Clean the area with an alcohol swab and let it dry completely before injecting. Remove the needle cap, press the pen firmly and flat against the skin, then press the injection button. Hold the pen in place until you hear or feel the second click, that confirms the full dose has been delivered and the needle has retracted. You do not need to aspirate or massage the area afterwards.
Place the used pen and needle directly into a sharps container; household bins are not appropriate for used needles under NHS disposal guidance. For a more detailed walkthrough of the KwikPen mechanism specifically, the KwikPen administration guide covers every stage with additional notes on troubleshooting.
The three permitted sites are the abdomen (at least 5 cm away from the navel), the front or outer thigh, and the outer upper arm. Each is equally effective. Some people find the abdomen easiest to reach; others prefer the thigh. The upper arm is a reasonable choice if someone else is helping you inject.
Rotating sites is not optional. Injecting repeatedly into exactly the same spot causes lipohypertrophy, a build-up of fatty tissue under the skin that can impair absorption and affect how consistently the medicine works. Rotate within each site (a few centimetres from the previous spot) and alternate between sites across weeks. A simple note in your phone after each injection is all you need to track it.
You can inject Mounjaro into a site used by a different subcutaneous medicine (insulin, for example) provided you choose a different spot within that area on that day. The NHS patient guidance on tirzepatide covers co-administration scenarios and is worth reviewing if you use more than one injectable medicine. For a broader look at what Mounjaro is and how it works, the Mounjaro overview on this site gives context on the dual GIP and GLP-1 mechanism behind once-weekly dosing.
Store unused pens in the fridge at 2–8°C, away from the freezer compartment and from the fridge-door shelf where temperatures can fluctuate. Once a pen is in use, a limited period at room temperature applies, check the Patient Information Leaflet for the exact window rather than relying on a general figure, because this detail can vary. Never freeze Mounjaro; a pen that has been frozen should not be used.
Missed doses and timing questions about titration are for your prescriber and the leaflet, not a webpage. The same applies to any decision about changing your dose. What is fair to say here is that if you experience injection-site reactions that are persistent, or any sign of a broader allergic response, you should contact a clinician rather than continuing to inject using the Mounjaro pen. The same goes for the symptoms described in the MHRA's guidance on GLP-1 medicines, severe or persistent stomach pain that spreads to the back should prompt urgent medical attention. The Yellow Card scheme lets you report any suspected side effects directly to the MHRA.
If you are considering starting Mounjaro and want to understand the cost alongside the clinical process, our Mounjaro price comparison guide sets out what to look for in a legitimate private provider. When you are ready, you can check your eligibility through a free consultation with one of our GPhC-registered prescribers, and if you would like more background beforehand, our page on what the Mounjaro injection involves and what it means for your treatment is a good starting point.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.